GlassScriptPhysician profile
Christina M Benn
NPI 1942787650
$2,248.21
in general payments reported to CMS, 2019-2025
20 companies · $742 in 2025
The $742 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $142 · 2021: $481 · 2022: $211 · 2023: $17.45 · 2024: $467 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $311.18 | 2020-2022 | |
| Abbvie INC. | $306.37 | 2022-2025 | |
| Alcon Vision LLC | $272.92 | 2019-2025 | Tryptyr, Total30, Dailies Total1 |
| Allergan, INC. | $224.99 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $176.80 | 2024 | Miebo, Xiidra, Envista Mx60 Iol |
| Tarsus Pharmaceuticals, INC. | $147.03 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $137.95 | 2024-2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $120.66 | 2019 | |
| Biotissue Holdings INC. | $90.64 | 2024-2025 | |
| Oyster Point Pharma, INC. | $90.51 | 2023-2025 | Tyrvaya, Ryzumvi |
| Eyevance Pharmaceuticals LLC | $89.61 | 2021 | |
| Sun Pharmaceutical Industries INC. | $87.22 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $43.23 | 2019-2020 | |
| Glaukos Corporation | $31.08 | 2025 | Idosetr, Istent Infinite |
| Lkc Technologies, INC. | $25.12 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $21.58 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Spark Therapeutics, INC. | $18.78 | 2019 | |
| Dompe US, INC. | $18.59 | 2025 | Oxervate |
| Horizon Therapeutics Plc | $17.57 | 2021 | |
| Sight Sciences, INC. | $16.38 | 2025 | Tearcare System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Benn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.